Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aspirin use in diabetics

This article was originally published in The Tan Sheet

Executive Summary

"A significant amount of work needs to be done to improve the adherence" of the American Diabetes Association's aspirin guidelines that the general diabetes mellitus (DM) population take aspirin as a prophylactic measure, Kenneth Nguyen, et al., Kansas City University of Medicine & Biosciences, report in the February Family Medicine. The retrospective analysis evaluated data from the 1997-2000 National Ambulatory Medical Care Survey to see if patients with DM who were over age 30 and had one or more risk factors for cardiovascular events were adhering to ADA recommendations. Findings showed only 2.7% of patients received aspirin in 1997, 2.9% in 1998, 2.1% in 1999 and 5.7% in 2000. Usage rates fell short of the roughly 33% of patients who should have been recommended for aspirin therapy, Nguyen et al. note...

Topics

UsernamePublicRestriction

Register

PS097915

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel